CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to HNSA.ST

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
HNSA.STPhase 2

GNT0003 Phase 2 Est. Readout

GNT0003
Sep 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Crigler-Najjar Syndrome

View Full Landscape
Drug Information

Target Indication

Crigler-Najjar Syndrome

Clinical Trial

NCT06518005

Last updated: 8/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.